viral
bacteri
sialidas
focus
drug
target
treatment
human
infect
soong
et
al
memoli
et
al
viral
sialidas
critic
requir
viral
propag
requir
releas
host
cell
kim
et
al
drug
discoveri
inhibitor
target
sialidas
focus
either
synthet
compound
random
screen
substrat
nacetylneuramin
acid
mimic
howev
studi
mainli
target
sialidas
influenza
viru
sever
inhibitor
mimic
substrat
includ
zanamivir
relenza
oseltamivir
tamiflu
cyclohexen
deriv
peramivir
cyclopentanebas
inhibitor
pyrrolidinebas
inhibitor
kim
et
al
compound
base
acid
put
transitionst
analogu
present
exist
drugresist
strain
zanamivir
gubareva
et
al
oseltamivir
gubareva
et
al
antivir
spur
need
discov
innov
antivir
agent
hand
pathogen
bacteria
resist
preexist
drug
occasion
caus
fatal
infecti
diseas
need
combat
superbug
mandat
develop
new
drug
overcom
antibacteri
resist
variou
pathogen
clostridium
perfringen
pseudomona
aeruginosa
streptococcu
pneumonia
express
sialidas
enzym
specif
catalyz
hydrolysi
termin
sialic
acid
glycoconjug
shinya
et
al
play
pivot
role
pathogenesi
number
microbi
diseas
includ
cholera
enterotoxaemia
ga
gangren
pneumonia
corfield
rood
therefor
bacteri
sialidas
recent
emerg
promin
target
treatment
bacteri
infect
nguyen
et
al
woo
et
al
latest
studi
sequela
sepsi
septic
shock
focus
understand
role
bacteri
pathogen
factor
rittirsch
et
al
moreov
studi
use
sialidas
delet
mutant
p
aeruginosa
show
bacteri
sialidas
act
initi
stage
pulmonari
infect
target
glycoconjug
biofilm
product
soong
et
al
sinc
sialidas
inhibitor
substrat
analogu
typic
exhibit
competit
kinet
interest
explor
natur
nonsubstr
mimic
flavonoid
oligo
coumarin
diarylheptanoid
grienk
et
al
flavonoid
polyphenol
compound
widespread
plant
kingdom
known
show
antibacteri
antivir
effect
liu
et
al
jeong
et
al
grienk
et
al
natur
flavonoid
also
report
latent
antiinfluenza
antibacteri
effect
sar
sever
acut
respiratori
syndrom
viru
mrsa
methicillinresist
staphylococcu
aureu
chaga
diseas
mediat
trypanosom
arioka
et
al
cho
et
al
et
al
recent
identifi
natur
geranyl
flavonoid
diplacon
mimulon
fruit
paulownia
tomentosa
empress
tree
show
potent
inhibitor
cholinesteras
butyrylcholinesteras
cho
et
al
report
geranyl
flavonoid
novel
inhibitor
target
bacteri
sialidas
compound
show
strike
competit
inhibitori
effect
sialidas
c
perfringen
cpnani
importantli
c
perfringen
human
pathogen
caus
variou
gastrointestin
diseas
enterotoxaemia
ga
gangren
periton
spite
report
number
structur
sialidas
bacteria
crennel
et
al
gaskel
et
al
virus
varghes
et
al
burmeist
et
al
crennel
et
al
human
chava
et
al
elucid
bind
mode
bacteri
sialidas
inhibitor
limit
owe
absenc
structur
inform
taylor
order
understand
natur
geranyl
flavonoid
interact
sialidas
determin
crystal
structur
cpnani
catalyt
domain
nanicd
residu
complex
diplacon
resolut
structur
inform
cpnanicd
comparison
model
human
sialidas
provid
insight
natur
geranyl
flavonoid
behav
antibiot
led
elucid
strategi
design
advanc
inhibitor
treatment
infecti
diseas
caus
c
perfringen
dna
templat
c
perfringen
sialidas
cpnani
ncbi
refer
sequenc
bacteri
express
nani
catalyt
domain
without
lectin
domain
nanicd
residu
amplifi
c
perfringen
genom
dna
polymeras
chain
reaction
clone
ndei
xhoi
restrict
site
express
vector
novagen
contain
direct
ctermin
hexahistidin
tag
cpnanicd
protein
express
escherichia
coli
codonplu
cell
transform
cell
cultur
lb
medium
contain
ampicillin
k
bacteri
cell
induc
k
h
mm
isopropyl
pharmacia
harvest
centrifug
min
harvest
cell
resuspend
lysi
buffer
mm
sodium
phosphat
ph
mm
nacl
mm
imidazol
mm
pmsf
mm
lyse
sonic
lysat
centrifug
h
result
supernat
appli
immobil
metalaffin
chromatographi
acid
resin
peptron
preequilibr
lysi
buffer
mm
sodium
phosphat
ph
mm
nacl
mm
imidazol
column
wash
ten
bed
volum
wash
buffer
fuse
protein
bound
column
elut
elut
buffer
mm
sodium
phosphat
ph
mm
nacl
mm
imidazol
sampl
purifi
sizeexclus
chromatographi
use
hiload
superdex
column
ge
healthcar
life
scienc
preequilibr
gelfiltr
buffer
mm
ph
mm
nacl
fraction
contain
cpnanicd
protein
collect
protein
concentr
mg
use
amicon
millipor
store
k
crystal
trial
perform
use
hangingdrop
vapourdiffus
method
crystal
grew
k
drop
compris
equal
volum
protein
solut
reservoir
solut
consist
wv
polyethylen
glycol
peg
ammonium
sulfat
crystal
soak
soak
solut
sodium
cacodyl
ph
wv
peg
wv
glycerol
mm
diplacon
vv
dimethyl
sulfoxid
h
k
crystal
cryoprotect
transfer
cryoprotect
wv
polyethylen
glycol
vv
glycerol
ammonium
sulfat
flashcool
liquid
nitrogen
data
collect
complet
data
set
cpnanicd
diplacon
resolut
collect
k
use
adsc
detector
beamlin
pohang
acceler
laboratori
pal
use
xray
beam
singl
wavelength
crystal
belong
space
group
unitcel
paramet
b
c
diffract
data
process
scale
use
suit
otwinowski
minor
structur
cpnanicd
diplacon
determin
use
molecularreplac
method
molrep
vagin
teplyakov
suit
winn
et
al
use
apo
crystal
structur
cpnanicd
pdb
entri
newstead
et
al
phase
model
autom
model
build
refin
nanicd
complex
diplacon
perform
murshudov
et
al
suit
phenixrefin
adam
et
al
phenixligandfit
terwillig
et
al
use
autom
ligand
build
diplacon
cpnanicd
manual
model
build
perform
coot
emsley
cowtan
weak
electrondens
region
residu
exclud
final
structur
ramachandran
statist
calcul
use
molprob
chen
et
al
residu
prefer
region
residu
allow
region
f
c
composit
omit
map
diplacon
contour
gener
fft
read
schierbeek
suit
atom
coordin
structur
factor
cpnanicd
diplacon
deposit
protein
data
bank
pdb
access
code
datacollect
refin
statist
summar
tabl
extract
purif
natur
geranyl
flavonoid
diplacon
mimulon
p
tomentosa
empress
tree
perform
describ
previous
cho
et
al
sialidas
inhibitori
assay
perform
report
previous
kim
et
al
cho
et
al
briefli
sialidas
solut
u
premix
sampl
solut
differ
concentr
mm
sodium
acet
buffer
ph
cuvett
mm
acid
sodium
salt
hydrat
sigma
catalogu
buffer
ph
ad
mixtur
substrat
start
reaction
k
immedi
quantifi
fluorometr
determin
spectramax
multimod
reader
molecular
devic
usa
excit
wavelength
nm
emiss
wavelength
nm
enzym
activ
record
rang
preincub
time
fig
concentr
fig
b
data
analyz
use
nonlinear
regress
program
sigmaplot
spcc
inc
chicago
illinoi
usa
experiment
enzym
activ
determin
use
logist
curv
repres
base
timedriven
protocol
initi
veloc
model
structur
human
sialidas
built
use
model
softwar
sali
blundel
human
protein
sequenc
retriev
ncbi
databas
basi
sequenc
structur
pdb
entri
chava
et
al
multipl
sequenc
align
structurebas
align
perform
use
larkin
et
al
model
sali
blundel
supplementari
fig
region
conserv
catalyt
domain
residu
residu
residu
exclud
model
carri
human
catalyt
domain
chosen
templat
pdb
entri
use
model
modelsingl
sali
blundel
supplementari
fig
ten
output
model
structur
rank
use
intern
score
function
model
reliabl
homolog
model
assess
calcul
rootmeansquar
deviat
rmsd
use
pymol
delano
supplementari
tabl
evalu
zscore
use
prosa
wiederstein
sippl
analysi
torsion
angl
use
procheck
laskowski
et
al
supplementari
tabl
order
demonstr
flavonoidbas
natur
compound
extract
p
tomentosa
act
inhibitor
cpnani
compar
activ
screen
perform
method
reli
substrat
hydrolysi
lead
increas
fluoresc
read
real
time
interestingli
geranyl
group
posit
within
flavonoid
found
crucial
inhibitori
potenc
kinet
mechan
exampl
diplacon
show
higher
efficaci
eriodictyol
parent
flavonoid
lack
geranyl
group
tabl
shown
fig
diplacon
show
competit
kinet
k
valu
diplacon
also
act
timedepend
inhibitor
slowbind
inhibit
mechan
investig
preincub
enzym
inhibitor
follow
measur
initi
veloc
substrat
hydrolysi
function
preincub
time
way
increas
concentr
diplacon
led
decreas
initi
veloc
v
steadyst
rate
v
fig
b
supplementari
fig
progress
curv
obtain
use
variou
concentr
inhibitor
fit
equat
supplementari
fig
determin
v
v
k
ob
result
diplacon
fit
slowbind
process
equat
supplementari
fig
illustr
hyperbol
depend
k
ob
concentr
bacteri
sialidas
fig
c
base
kinet
observ
conclud
reaction
follow
timedepend
kinet
mechan
fig
result
fit
valu
obtain
k
k
respect
use
valu
deriv
k
ob
give
calcul
k
app
valu
agreement
k
valu
determin
use
doublereciproc
plot
dixon
plot
supplementari
fig
hyperbol
depend
observ
inhibitor
suggest
diplacon
inhibit
sialidas
rapid
format
enzym
complex
slowli
isomer
form
modifi
enzym
complex
fig
supplementari
fig
comparison
structur
sialidas
bacteria
crennel
et
al
gaskel
et
al
virus
varghes
et
al
burmeist
et
al
crennel
et
al
human
chava
et
al
suggest
sialidas
share
highli
conserv
activ
site
locat
within
sixblad
fold
supplementari
tabl
supplementari
fig
investig
mode
bind
diplacon
enzym
determin
structur
cpnani
complex
diplacon
structur
cpnanicd
complex
diplacon
show
littl
deviat
previous
publish
structur
fold
within
apo
structur
pdb
entri
newstead
et
al
structur
cpnani
complex
substrat
acid
pdb
entri
newstead
et
al
show
rootmeansquar
deviat
rmsd
rel
structur
respect
fig
consist
kinet
analysi
diplacon
bound
enzym
activ
site
princip
interact
inhibitor
enzym
hydrogen
bond
hydrophob
interact
group
atom
diplacon
form
direct
indirect
hydrogen
bond
side
chain
triarginyl
cluster
well
residu
main
chain
addit
three
water
molecul
fig
b
supplementari
fig
flavanon
backbon
diplacon
also
display
hydrophob
contact
orient
inhibitor
correctli
stabil
bound
conform
crystal
structur
also
provid
explan
weak
inhibit
shown
parent
eriodictyol
three
geranyl
flavonoid
mimulon
studi
manuscript
tabl
fig
b
geranyl
group
made
suitabl
hydrophob
interact
four
aromat
residu
therefor
diplacon
show
approxim
higher
inhibitori
effect
compar
eriodictyol
lack
geranyl
group
hydroxyl
group
diplacon
also
made
addit
hydrogen
bond
mainchain
n
atom
introduc
methyl
posit
adjac
would
disturb
hydrogen
bond
caus
steric
hindranc
main
chain
side
chain
hand
elimin
hydroxyl
group
mimulon
lead
structur
clash
protein
prevent
hydrogenbond
format
therefor
maintain
geranyl
hydroxyl
group
import
develop
diplaconebas
cpnani
inhibitor
although
overal
structur
cpnanicd
complex
diplacon
similar
apo
enzym
complex
interest
structur
differ
apo
enzym
complex
diplacon
provid
use
inform
regard
develop
natur
geranyl
flavonoidbas
synthet
inhibitor
fig
b
diplacon
complex
mechanist
import
acidbas
catalyst
crennel
et
al
rotat
approxim
compar
apo
structur
make
hydrogen
bond
diplacon
moreov
rotat
also
induc
conform
chang
apo
enzym
compar
complex
rel
diplaconebound
complex
complex
move
make
suitabl
hydrophob
interact
moieti
molecul
apo
cpnanicd
diplacon
complex
show
hydrogenbond
interact
mediat
one
water
molecul
posit
nearli
overlap
group
hand
hydrogen
bond
group
seem
respons
induc
conform
chang
cpnanicd
complex
diplacon
sidechain
orient
substrat
complex
addit
extra
water
molecul
rather
group
stabil
diplacon
complex
therefor
togeth
kinet
inhibit
assay
structur
complex
suggest
diplacon
bind
substratebind
site
act
competit
inhibitor
extract
natur
geranyl
flavonoid
p
tomentosa
shown
exhibit
notabl
kinet
properti
sialidas
c
perfringen
bacterium
caus
variou
gastrointestin
diseas
also
found
diplacon
effect
inhibitor
among
flavonoid
inhibitor
also
show
timedepend
competit
inhibit
pattern
crystal
structur
cpnani
catalyt
domain
complex
diplacon
ration
geranyl
hydroxyl
group
diplacon
contribut
stabil
complex
tabl
structur
inform
describ
suggest
modif
strategi
diplacon
improv
inhibitori
properti
c
perfringen
nani
complex
two
water
molecul
mediat
hydrogen
bond
cpnani
residu
catalyt
site
diplacon
atom
tabl
fig
b
introduc
polar
moieti
carboxyl
amino
group
posit
diplacon
may
possibl
improv
bind
affin
cpnani
catalyt
site
format
addit
hydrogen
bond
addit
hydrophob
group
includ
phenyl
benzyl
cyclohexyl
group
diplacon
may
also
increas
bind
affin
via
hydrophob
contact
hydrophob
patch
enzym
furthermor
aryl
group
phenyl
benzyl
may
form
potenti
interact
sialidas
express
c
perfringen
also
human
lysosom
cytosol
membran
diplacon
could
caus
undesir
effect
human
may
inhibit
human
sialidas
predict
diplacon
would
interact
human
silalidas
counterpart
model
human
sialidas
use
previous
determin
structur
compar
specif
diplacon
c
perfringen
human
sialidas
fig
supplementari
fig
cpnani
catalyt
domain
bound
diplacon
superimpos
crystal
structur
human
bound
acid
model
human
construct
use
templat
geranyl
group
diplacon
essenti
inhibit
bacteri
enzym
occupi
hydrophob
pocket
contain
human
neu
protein
correspond
residu
polar
would
interact
favour
geranyl
group
fig
b
consequ
structur
comparison
human
sialidas
complex
suggest
interact
human
sialidas
diplacon
like
unfavour
owe
polar
ionic
repuls
hand
despit
extens
effort
drug
develop
target
influenza
neuraminidas
seri
drugresist
mutant
influenza
virus
report
dual
mutat
neuraminidas
influenza
show
enorm
resist
toward
oseltamivir
approxim
time
wild
type
van
der
vri
et
al
overcom
drug
resist
variou
natur
flavonoid
compound
contain
flavanon
backbon
inhibitori
effect
viral
neuraminidas
grienk
et
al
may
use
diplacon
flavanon
backbon
structur
inform
complex
would
help
discoveri
viral
neuraminidas
inhibitor
light
compar
structur
complex
two
structur
drugresist
mutant
viral
neuraminidas
mutant
mutant
examin
use
diplacon
influenza
viral
neuraminidas
despit
low
sequenc
ident
low
homolog
viral
neuraminidas
influenza
iana
b
ibna
cpnanicd
ident
iana
ibna
homolog
iana
ibna
overal
structur
well
conserv
supplementari
fig
moreov
diplacon
seem
access
regardless
mutat
hydroxyl
group
posit
diplacon
abl
interact
mutant
wild
type
suggest
diplacon
may
potenti
lead
compound
develop
inhibitor
drugresist
mutant
viral
neuraminidas
supplementari
fig
summari
isol
geranyl
flavonoid
diplacon
mimulon
p
tomentosa
show
inhibitori
activ
cpnani
use
compar
activ
screen
first
crystal
structur
sialidas
geranyl
flavonoid
provid
structur
insight
bind
mode
natur
flavonoidbas
inhibitor
atom
resolut
higher
inhibitori
potenc
diplacon
rel
compound
studi
ascrib
two
princip
factor
firstli
group
stabil
complex
hydrogen
bond
main
chain
secondli
addit
hydrophob
interact
observ
geranyl
group
hydrophob
pocket
form
activ
site
importantli
four
variant
human
sialidas
pocket
significantli
differ
polar
would
expect
interact
favor
geranyl
group
human
conserv
bacteri
viral
sialidas
consid
import
site
design
select
drug
target
bacteria
virus
burmeist
et
al
howev
biochem
structur
data
suggest
hydrophob
bind
pocket
cpnani
bind
geranyl
group
within
diplacon
may
also
exploit
mean
deriv
select
bacteri
versu
human
sialidas
result
provid
valuabl
inform
design
new
select
antibacteri
antivir
agent
use
flavonoid
follow
refer
cite
support
inform
nichola
deerfield
sali
blundel
chava
et
al
newstead
et
al
luo
et
al
telford
et
al
buschiazzo
et
al
crennel
et
al
xu
et
al
varghes
et
al
